Shanghai MicroPort MedBot (Group) Co., Ltd. announce that the SkyWalker Orthopedic Surgical Robot (overseas product name: SkyWalkerTM, SkyWalker'') independently developed by the Group has passed the review of the Brazilian Health Regulatory Agency (ANVISA') and has been approved for marketing in Brazil. This represents another important progress of SkyWalker made by the Group after the successive obtaining of the marketing approval from the National Medical Products Administration (the ``NMPA''), the clearance from the U.S. Food and Drug Administration (the FDA') and the CE Mark last year.
Shanghai MicroPort MedBot (Group) Co., Ltd.
Equities
2252
CNE100004QP1
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16 HKD | +1.01% | +1.91% | -23.26% |
05-10 | EU Grants CE Mark to Shanghai Medbot's Laparoscopic Surgical Robot | MT |
03-27 | Shanghai MicroPort MedBot Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.26% | 1.96B | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- 2252 Stock
- News Shanghai MicroPort MedBot (Group) Co., Ltd.
- Shanghai MicroPort MedBot Co., Ltd. Announces Skywalker Orthopedic Surgical Robot Obtained the ANVISA Certification in Brazil